James Schultz

Array ( [id] => 5479638 [patent_doc_number] => 20090202595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'ANTI-PDEF ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/342037 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19050 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202595.pdf [firstpage_image] =>[orig_patent_app_number] => 12342037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527209 [patent_doc_number] => 08043801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Method of screening for agents to treat heart failure' [patent_app_type] => utility [patent_app_number] => 12/313539 [patent_app_country] => US [patent_app_date] => 2008-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 25151 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043801.pdf [firstpage_image] =>[orig_patent_app_number] => 12313539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152099 [patent_doc_number] => 08168586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-05-01 [patent_title] => 'Cancer targets and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/275779 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 42172 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168586.pdf [firstpage_image] =>[orig_patent_app_number] => 12275779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9285748 [patent_doc_number] => 08642074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Thermosensitive liposomes containing therapeutic agents' [patent_app_type] => utility [patent_app_number] => 12/741364 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7094 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987392 [patent_doc_number] => 20110098346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'NUCLEIC ACID MOLECULE AND METHOD OF TARGETING GENE EXPRESSION TO GLIOMAS' [patent_app_type] => utility [patent_app_number] => 12/993787 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14923 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098346.pdf [firstpage_image] =>[orig_patent_app_number] => 12993787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534203 [patent_doc_number] => 20090233991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'GENERATION OF BIOLOGICAL PACEMAKER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/263295 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10110 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233991.pdf [firstpage_image] =>[orig_patent_app_number] => 12263295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534202 [patent_doc_number] => 20090233990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'GENERATION OF BIOLOGICAL PACEMAKER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/263281 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10110 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233990.pdf [firstpage_image] =>[orig_patent_app_number] => 12263281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134464 [patent_doc_number] => 20110008366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'INHIBITION OF VERSICAN WITH SIRNA AND OTHER MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/677435 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17384 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008366.pdf [firstpage_image] =>[orig_patent_app_number] => 12677435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11256997 [patent_doc_number] => 09481892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-01 [patent_title] => 'Controlled activation of non-LTR retrotransposons in mammals' [patent_app_type] => utility [patent_app_number] => 12/740943 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11192 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12740943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293956 [patent_doc_number] => 08221738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Method for enhanced uptake of viral vectors in the myocardium' [patent_app_type] => utility [patent_app_number] => 12/260953 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19153 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12260953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448131 [patent_doc_number] => 20100105139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents' [patent_app_type] => utility [patent_app_number] => 12/259148 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9410 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105139.pdf [firstpage_image] =>[orig_patent_app_number] => 12259148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6263297 [patent_doc_number] => 20100297234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'METHOD OF USING AN EXTRACELLULAR MATRIX TO ENHANCE CELL TRANSPLANT SURVIVAL AND DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 12/738839 [patent_app_country] => US [patent_app_date] => 2008-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12702 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297234.pdf [firstpage_image] =>[orig_patent_app_number] => 12738839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624029 [patent_doc_number] => 08003324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Modulation of sodium channels by nicotinamide adenine dinucleotide' [patent_app_type] => utility [patent_app_number] => 12/289005 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10140 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003324.pdf [firstpage_image] =>[orig_patent_app_number] => 12289005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5443066 [patent_doc_number] => 20090094705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'LABORATORY-SELECTED COLONIES OF WESTERN CORN ROOTWORM WITH INCREASED TOLERANCE TO MAIZE CONTAINING EVENT DAS-59122-7' [patent_app_type] => utility [patent_app_number] => 12/244845 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15387 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20090094705.pdf [firstpage_image] =>[orig_patent_app_number] => 12244845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574941 [patent_doc_number] => 20090142302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/209028 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17920 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142302.pdf [firstpage_image] =>[orig_patent_app_number] => 12209028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234784 [patent_doc_number] => 20100186102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Methods and compositions for post-transcriptional gene silencing' [patent_app_type] => utility [patent_app_number] => 12/673575 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8684 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20100186102.pdf [firstpage_image] =>[orig_patent_app_number] => 12673575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336705 [patent_doc_number] => 20090053169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Oligonucleotide Core Carrier Compositions for Delivery of Nucleic Acid-Containing Therapeutic Agents, Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 12/194144 [patent_app_country] => US [patent_app_date] => 2008-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 30940 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053169.pdf [firstpage_image] =>[orig_patent_app_number] => 12194144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202023 [patent_doc_number] => 20110064809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'SCAFFOLDS' [patent_app_type] => utility [patent_app_number] => 12/673600 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5454 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064809.pdf [firstpage_image] =>[orig_patent_app_number] => 12673600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030888 [patent_doc_number] => 20110081317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Enhancing Gene Transfer' [patent_app_type] => utility [patent_app_number] => 12/672386 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11199 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081317.pdf [firstpage_image] =>[orig_patent_app_number] => 12672386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7800674 [patent_doc_number] => 08128944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles' [patent_app_type] => utility [patent_app_number] => 12/670697 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 49 [patent_no_of_words] => 32457 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128944.pdf [firstpage_image] =>[orig_patent_app_number] => 12670697 [rel_patent_id] =>[rel_patent_doc_number] =>)